[China Shandong] Xinhua Pharmaceutical manufacturing innovation oriented state-owned enterprises international scale first
Date:2014-07-29 Author: Click:
Chinese Shandong network August 7th news (reporter Zhou Yusen) a republic is older than "red" in Zibo city of Shandong Pharmaceutical enterprises. 70 years ago, it consists of 18 eight Army soldiers in war-torn Jiaodong Anti Japanese front line was set up 70 years later, it became to the relationship between public safety and health for the purpose of the famous large pharmaceutical companies, it is Shandong Xinhua Pharmaceutical Limited by Share Ltd (hereinafter referred to as Xinhua Pharmaceutical).
Entering the twenty-first Century, the 70 year professional pharmaceutical history enterprise has formed a new development path based on talent strategy, innovating research and development, and making products and other products to export to the international market.
Creating talent pharmaceutical enterprises to realize product innovation
Talent is the key to the success of the enterprise. In the long-term development process, the Xinhua Pharmaceutical industry has gradually formed a sound and perfect talent cultivation mechanism. In 2012, Xinhua Pharmaceutical "academician workstation" and "Taishan scholar research post" was unveiled. China Academy of engineering, director, Su Zhen Yong Academy of Medical Sciences Institute of medical biotechnology China scholar of Taishan pharmaceutical distinguished experts Professor Shao Rongguang as the core of the team, to provide strong support for improving the ability of independent innovation for the enterprise in the field of high technology research and development and transformation of scientific and technological achievements.
At present, Xinhua Pharmaceutical has a high-tech talent team composed of 8 Ph.D., more than 70 master's degree, and over 800 undergraduates. They play a great role in the technological innovation of enterprises. With the industrial production of major scientific and technological achievements in new drug research and development, the development of talent support enterprises is becoming more and more effective.
350 million pieces of ibuprofen export to high end market in Europe and America
Reporters learned that since the 80s of last century, Xinhua Pharmaceutical has introduced the drug production quality management standard (GMP) in the US and Europe, and guided the production according to the GMP code and ICHQ7 in Europe and America. When the quality concept of ICHQ9/ quality risk management, ICHQ10/ quality management system and quality originate from design (QbD) prevails in Europe and America, Xinhua Pharmaceutical timely introduces and absorbs, and updates its own quality concept and management system based on this guidance.
In the Xinhua pharmaceutical quality management system, quality of products meet the statutory standards are the minimum requirements of the enterprise, Xinhua Pharmaceutical for raw materials and finished products were made higher than the statutory standard of "enterprise internal control standard", ensure the products sold is not only in line with national standards, at the same time, but also to ensure that products throughout their life cycle. The quality, stability, delivery of the drugs are effective and safe, let people be assured of drugs.
At present, all pharmaceutical products and dosage forms of Xinhua Pharmaceutical have been approved by the national GMP, and several products have been registered in many countries, such as the US, Russia and India. Especially in 2011, Xinhua Pharmaceutical preparation workshop also got the cGMP certificate issued by the British medicines and health products administration, which is effective in 27 European Union countries. Through the EU GMP certification marks Xinhua Pharmaceutical Products in the preparation plant, facilities, equipment, product quality, quality assurance system fully comply with EU GMP requirements, reached the international advanced level, but also means that the 27 members of the European Union's high-end medical market opened the door to a new Chinese medicine. In 2013, the company will export 350 million pieces of ibuprofen to the high-end market
In the aseptic operation of the Xinhua Pharmacy, the workers were carefully operated on their posts.
In 2013 to invest 20 million yuan built using solid waste incineration energy projects.
Changing the pipe and controlling the waste water to build a green pharmaceutical enterprise
Energy saving, low carbon, green and environmental protection are both the new requirements of the state for economic and social development under the new situation, and also the inevitable choice for enterprises to achieve healthy and sustainable development in the way of transformation, restructuring and promoting development.
"In terms of energy saving, 2012 Xinhua Pharmaceutical achieve million comprehensive energy consumption down 4.086%, to achieve annual energy reduction of 3286 tons of standard coal, and the government signed the annual energy converted to standard coal 133.79%, has completed the signing of" 12th Five-Year "energy saving target and municipal government 53.3%, the indicators are achieved exceeded." Du Deqing, the deputy general manager of the energy conservation work, said.
Xinhua Pharmaceutical Products Analginum had two large old chimney 45 meters high, in order to reduce emissions and reduce odor, they invested heavily in the construction of the three absorption tower, and creatively improved the absorption device and the absorption liquid and finally solve the exhaust emission problem of products, to achieve the "invisible smoke, don't smell the taste of the standard".
The wastewater produced during the production of caffeine has high salinity, high content of multi ring and heterocyclic refractory organic matter, high organic nitrogen content, and COD removal and ammonia nitrogen removal are very difficult. All the manufacturers of caffeine production in China have not achieved good effect on the treatment of caffeine wastewater. The Xinhua Pharmaceutical organization, a number of Environmental Engineering Company, carried out experiments and tackled the problems. Finally, a new treatment process of the wastewater in the experiment made a breakthrough, can achieve more than 70% COD removal rate in the operation, in order to completely solve the problem of the company, low efficiency of sewage treatment facilities.
Recently, Xinhua Pharmaceutical investment more than 2000 yuan to the construction of solid waste incineration energy projects and walk in the forefront of the province and the city, according to deputy director of Xinhua Pharmaceutical environmental protection department Bi Wenpu introduced, solid waste incineration energy project is the first in Zibo City, the project is divided into two levels of material, incineration, waste heat utilization, rapid cooling neutralization and multi-stage dust removing processes, equipment, high degree of automation, the flue gas after treatment could reach the national emission standards.
Inherit the red gene and dedicate the love of the enterprise
The history of the 70 years of pharmaceutical development has made new Chinese socially responsible, which is proved by a series of data and a line of footprints. Speaking of corporate responsibility, Zhang Daiming, the chairman of the Xinhua Pharmaceutical Group and the Secretary of the Party committee, had a profound experience.
In 2008, the "5.12 Wenchuan earthquake" occurred, Xinhua Pharmaceutical drug donations for the disaster area, amounting to more than 380 yuan; the donor value of 22 yuan of emergency medicine in 2008 4.28 Jiaoji railway accident; 2010 Yushu earthquake donated 209 thousand and 100 Yuan love medicine.
Only 8 hours after the 2013 Ya'an earthquake in Sichuan, under the guidance of Du Deping, general manager of the company and vice general manager He Tongqing, the victims who were full of Xinhua loved 120 thousand yuan were badly in need of drugs for the first time to the disaster area. In addition, the past 3 years, Xinhua Pharmaceutical also has to Zibo City charity donations totaling more than 1 million yuan, has won the "Chinese CSR Award", "national support for public welfare, the heart of the people health enterprise", "Zibo City charity work advanced collective" honorary title.
Xinhua Pharmaceutical for the future development of the road, Zhang Daiming told reporters, Xinhua has inherited forged fire in the enterprising spirit, will continue to "talent, quality, energy saving and emission reduction, responsibility, honesty" as the goal, in the protection of health, benefit the society "the mission of the enterprise under the guidance for the staff responsible, responsible for the product responsible for enterprise, healthy, responsible, cordial responsibility of pharmaceutical